CELLINK has been granted project funding from Horizon 2020
CELLINK AB ("CELLINK" or "The Company") has been awarded project financing with partners. The company's share of the project corresponds to an amount of EUR 350,000, of which the EU accounts for 100 percent of the cost. CELLINK has been awarded project funding from the EU for the project "SilkFUSION - Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo platelet production, transfusion and drug research" through "Horizon 2020 - Novel ideas for radically new technologies ". Together with 6